© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Leader

Top Section/Ad

Top Section/Ad

Most recent


The necessity of clauses that help developing countries recover from catastrophes is getting more acute
Data-deprived markets should give the shutdown the attention it deserves
Triple-C loan pricing has been shunted wider while the true credit quality of loans trading at par is obscured
Credit Suisse AT1 bondholders should consider alternatives after this week's sharp repricing
More articles/Ad

More articles/Ad

More articles

  • Speculation is rife that the European Central Bank will mimic the US Federal Reserve’s ‘Operation Twist’ from a few years ago, focusing reinvestments from redeeming bonds bought under the public sector purchase programme into long dated paper. While there has been some impact from the news, any benefit is likely to be limited.
  • It shouldn't be unreasonable to dream of a full disclosure of minimum requirements for own funds and eligible liabilities (MREL) for EU banks.
  • Corporate treasurers are sometimes portrayed as risk averse individuals who pore over financial models to deliver the safest funding for their companies. They do, however, also have a responsibility to raise those funds at the lowest cost. Pragmatism is a trait companies should value highly in a treasurer.
  • Other than balance sheets, all banks have to offer is their people. And this week, Nomura made an unusually large statement, hiring three of them at once to bulk up its EMEA rates business.
  • When Sanofi raised all €8bn of the funding it needed for its acquisitions of Ablynx and Bioverativ in March, much was made of how this showed the capability of the European market to take down large M&A financings. But if Europe is now so capable, why then did Bayer, one of Germany’s brightest corporate stars, take 75% of the €22bn of financing it needed to buy Monsanto from the US instead?
  • The European Investment Bank deserves serious plaudits for taking the plunge this week with a sterling floating rate note that pays coupons linked to Sonia rather than Libor — no matter how well the deal goes.